M&A Speculated. Unlikely to be large enough to need issuance.
• Following its setback in the obesity market, analysts are speculating that Pfizer may have to pursue M&A to enter this lucrative growth area
• Names such as Viking ($2.8bn mkt cap; $1.9bn EV) have been mentioned
• Pfizer has $15bn earmarked for acquisitions this year
• “If they want to be in this space, they’re going to have to do a deal,” BMO analyst Evan Seigerman said. “They really needed a win, and they didn’t get it.” – Bloomberg reports
• Pfizer currently only has one ISIN in EUR: PFE 1% Mar 27 but had 9 other bonds in the past.
Find more articles and bullets on these widgets:
The MNI Markets Team’s expectations for the updated Economic Projections in the March SEP are below.

Amid rising government policy uncertainty, sentiment among businesses and consumers has fallen sharply since the start of the year, while equities and the dollar have reversed their post-election rise. Overall, financial conditions have tightened, even if stress is not yet mounting, e.g. no major widening of credit spreads (the accompanying chart shows the Fed’s financial conditions impulse index but only through January).

